Hypha Labs, Inc.
FUNI
$0.03
$0.00-7.87%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 67.15% | 121.22% | 289.26% | 1,116.28% | 522.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.15% | 121.22% | 289.26% | 1,116.28% | 522.26% |
| Operating Income | -67.15% | -121.22% | -289.26% | -1,116.28% | -522.26% |
| Income Before Tax | -128.68% | -188.67% | -578.47% | -337.65% | -93.14% |
| Income Tax Expenses | -- | -145.38% | -170.84% | -- | -- |
| Earnings from Continuing Operations | -126.31% | -180.57% | -508.12% | -340.08% | -95.16% |
| Earnings from Discontinued Operations | -- | -100.00% | -100.00% | -76.07% | -38.35% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -294.88% | -5,053.08% | -434.85% | -456.46% | -418.27% |
| EBIT | -67.15% | -121.22% | -289.26% | -1,116.28% | -522.26% |
| EBITDA | -162.92% | -358.96% | -8,701.74% | -6,283.38% | -918.63% |
| EPS Basic | -280.65% | -3,485.71% | -342.59% | -352.70% | -321.43% |
| Normalized Basic EPS | -23.73% | -45.63% | -109.09% | -314.29% | -145.83% |
| EPS Diluted | -198.96% | -966.67% | -421.30% | -398.65% | -442.86% |
| Normalized Diluted EPS | -23.73% | -45.63% | -109.09% | -314.29% | -145.83% |
| Average Basic Shares Outstanding | 33.37% | 36.68% | 37.57% | 30.07% | 20.79% |
| Average Diluted Shares Outstanding | 33.37% | 36.68% | 37.57% | 30.07% | 20.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |